Previous studies have demonstrated a potential advantage of using glucagon in fasting—induced hypoglycemia, children and during exercise, yet this is the first real—world evaluation that presents data on using MDG for hypoglycemia in prolonged, repetitive fasting situations [3,9,17]. The gene discussed is GCG; the disease is Hypoglycemia.